Myelofibrosis (MF) is a heterogeneous disorder with multiple characteristics dominated by the effects of progressive bone marrow fibrosis. The goal of this learning activity is to provide doctors with a review of MF.
Upon completing this module, participants will have a better understanding of its:
• Epidemiology and pathophysiology
• Clinical presentation
• Diagnosis and prognosis
• Path to referral
Dr Haifa Kathrin Al-Ali, MD, PD
Department of Haematology and Medical Oncology
University Hospital of Halle (Saale)
• Q&A session
Who should participate:
Please watch the video before attempting the assessment questions.
Terms & Conditions:
■ Participants must obtain a minimum score of 8/10 (80%) to be awarded 1 point.
■ MIMS Education and MIMS Medica shall not be responsible or liable for the outcome of your CPD points
To play this video, you are required to have a media player such as Windows Media Player (PC), QuickTime (MAC) or another third party media player.